(function(){var loadHandler=window['sl_{8824A113-B472-4E24-968F-C628FF6E319A}'];loadHandler&&loadHandler(18, '<div id="spr0_39dc80"><div id="spr1_39dc80" class="kern"><img id="img3_39dc80" src="data/img2.png" width="960px" height="540px" alt="" style="left:0px;top:0px;"/><div id="spr3_39dc80"><img id="img0_39dc80" src="data/img0.png" width="960" height="540" alt=""/></div></div><div id="spr2_39dc80" class="kern"><div id="spr4_39dc80" style="left:32.076px;top:88.563px;"><img id="img1_39dc80" src="data/img32.png" width="820" height="223" alt="" style="left:0.175px;top:-0.139px;"/></div><div id="spr5_39dc80" style="left:39.585px;top:303.643px;"><img id="img2_39dc80" src="data/img33.png" width="813" height="143" alt="" style="top:-0.25px;"/></div><div id="svg0_39dc80" style="left:734.175px;top:35.372px;"><svg width="187" height="47" viewBox="-1 -1 187 47"><path fill="#92d050" stroke="#085091" stroke-width="2" stroke-linecap="butt" stroke-linejoin="round" d="M1,1 h182.937 v42.111 h-182.937 Z"/></svg></div><div id="spr6_39dc80" style="left:735.175px;top:36.372px;"><div style="width:0px;"><span id="txt0_39dc80" class="relpos" style="left:22.649px;top:-1.192px;">Dx efficacy</span></div></div><div id="spr7_39dc80" style="left:623.582px;top:510.594px;"><div style="width:0px;"><span id="txt1_39dc80" class="relpos" style="left:7.2px;top:1.323px;">Gastrointest Endosc 2008;67:660-8</span></div></div><div id="spr8_39dc80" style="left:84.251px;top:446.689px;"><div style="width:0px;"><span id="txt2_39dc80" class="relpos" style="left:7.2px;top:0.817px;">In 23 cases of high risk group, only 8 cases were converted to ERCP after EUS.</span></div><div style="width:0px;"><span id="txt3_39dc80" class="relpos" style="left:7.2px;top:27.217px;">In other words, EUS-based strategy avoid 65% unnecessary ERCP in high risk group.</span></div></div></div></div>');})();